CMS Issues Guidance On RA, Other Programs In Light Of NM Court Ruling

July 13, 2018
CMS Thursday released additional, largely technical, guidance to issuers in light of the New Mexico court's order to vacate the risk adjustment program, reiterating the 2017 payments and collections will be halted, but also noting the agency will still collect user fees from issuers for the plan year since they are not reliant on the budget-neutral methodology rejected by the court. “CMS is actively litigating this case and appreciates issuers’ patience while this case is in litigation,” the agency writes...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.